Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2010 Oct 01;1613:589-600. doi: 10.1111/j.1476-5381.2010.00888.x.
Show Gene links
Show Anatomy links
The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.
Frølund S
,
Holm R
,
Brodin B
,
Nielsen CU
.
???displayArticle.abstract???
BACKGROUND AND PURPOSE The intestinal proton-coupled amino acid transporter, SLC36A1, transports zwitterionic α-amino acids and drugs such as vigabatrin, gaboxadol and δ-aminolevulinic acid. We hypothesize that SLC36A1 might also transport some dipeptides. The aim of the present study was to investigate SLC36A1-mediated transport of Gly-Gly and Gly-Gly mimetics, and to investigate Gly-Sar transport via SLC36A1 and the proton-coupled dipeptide/tripeptide transporter, SLC15A1 in Caco-2 cells. EXPERIMENTAL APPROACH Transport of a compound via SLC36A1 was determined by its ability to induce an increase in the inward current of two-electrode voltage clamped SLC36A1 cRNA-injected Xenopus laevis oocytes. SLC36A1-mediated L-[³H]Pro uptake in Caco-2 cells was measured in the absence and presence of Gly-Gly or Gly-Sar. In addition, apical [¹⁴C]Gly-Sar uptake was measured in the absence and presence of the SLC36A1 inhibitor 5-hydroxy-L-tryptophan (5-HTP) or the SLC15A1 inhibitor L-4,4'-biphenylalanyl-L-proline (Bip-Pro). KEY RESULTS In SLC36A1-expressing oocytes, an inward current was induced by Gly-Sar, Gly-Gly, δ-aminolevulinic acid, β-aminoethylglycine, δ-aminopentanoic acid, GABA, Gly and Pro, whereas Val, Leu, mannitol, 5-HTP and the dipeptides Gly-Ala, Gly-Pro and Gly-Phe did not evoke currents. In Caco-2 cell monolayers, the apical uptake of 30 mM Gly-Sar was inhibited by 20 and 22% in the presence of 5-HTP or Bip-Pro, respectively, and by 48% in the presence of both. CONCLUSION AND IMPLICATIONS Our results suggest that whereas Gly-Gly amid bond bioisosteres are widely accepted by the hPAT1 carrier, dipeptides in general are not; and therefore, Gly-Sar might structurally define the size limit of dipeptide transport via SLC36A1.
Abbot,
Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.
2006, Pubmed,
Xenbase
Abbot,
Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.
2006,
Pubmed
,
Xenbase
Addison,
Evidence for active transport of the dipeptide glycylsarcosine by hamster jejunum in vitro.
1972,
Pubmed
Alexander,
Guide to Receptors and Channels (GRAC), 3rd edition.
2008,
Pubmed
Anderson,
Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+- and Cl(-)-dependent TauT (SLC6A6).
2009,
Pubmed
,
Xenbase
Anderson,
Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine.
2010,
Pubmed
,
Xenbase
Boll,
Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters.
2002,
Pubmed
,
Xenbase
Boll,
Substrate recognition by the mammalian proton-dependent amino acid transporter PAT1.
2003,
Pubmed
,
Xenbase
Botka,
Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics.
2000,
Pubmed
Bowery,
Depolarizing actions of gamma-aminobutyric acid and related compounds on rat superior cervical ganglia in vitro.
1974,
Pubmed
Brandsch,
The intestinal H+/peptide symporter PEPT1: structure-affinity relationships.
2004,
Pubmed
Chen,
Structure, function and immunolocalization of a proton-coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco-2.
2003,
Pubmed
Daniel,
Molecular and integrative physiology of intestinal peptide transport.
2004,
Pubmed
Döring,
Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.
1998,
Pubmed
,
Xenbase
Foltz,
Kinetics of bidirectional H+ and substrate transport by the proton-dependent amino acid symporter PAT1.
2005,
Pubmed
,
Xenbase
Frølund,
Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1).
2010,
Pubmed
Gebauer,
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
2003,
Pubmed
Hu,
Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine.
2008,
Pubmed
Jensen,
Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
2006,
Pubmed
,
Xenbase
Knütter,
Synthesis and characterization of a new and radiolabeled high-affinity substrate for H+/peptide cotransporters.
2007,
Pubmed
,
Xenbase
Larsen,
Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells.
2008,
Pubmed
Larsen,
Intestinal gaboxadol absorption via PAT1 (SLC36A1): modified absorption in vivo following co-administration of L-tryptophan.
2009,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Metzner,
Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
2004,
Pubmed
Metzner,
The orally active antihyperglycemic drug beta-guanidinopropionic acid is transported by the human proton-coupled amino acid transporter hPAT1.
2009,
Pubmed
,
Xenbase
Metzner,
Serotonin, L-tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1.
2005,
Pubmed
,
Xenbase
Muhyaddin,
Presynaptic gamma-aminobutyric acid receptors in the rat anococcygeus muscle and their antagonism by 5-aminovaleric acid.
1982,
Pubmed
Nielsen,
Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line.
2001,
Pubmed
Nielsen,
Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.
2003,
Pubmed
Nielsen,
Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
2003,
Pubmed
Samuels,
Anticonvulsant activity of glycylglycine and delta-aminovaleric acid: evidence for glutamine exchange in amino acid transport.
1983,
Pubmed
Thwaites,
D-cycloserine transport in human intestinal epithelial (Caco-2) cells: mediation by a H(+)-coupled amino acid transporter.
1995,
Pubmed
Thwaites,
The role of the proton electrochemical gradient in the transepithelial absorption of amino acids by human intestinal Caco-2 cell monolayers.
1995,
Pubmed
Thwaites,
L-alanine absorption in human intestinal Caco-2 cells driven by the proton electrochemical gradient.
1994,
Pubmed
Thwaites,
H(+)-coupled (Na(+)-independent) proline transport in human intestinal (Caco-2) epithelial cell monolayers.
1993,
Pubmed
Thwaites,
Gamma-Aminobutyric acid (GABA) transport across human intestinal epithelial (Caco-2) cell monolayers.
2000,
Pubmed
Waidelich,
Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer.
2001,
Pubmed
Zaak,
Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid--first clinical experiences.
2008,
Pubmed
